These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2013-005024-42||A Randomized, Double-Blind, Placebo-Controlled, Study of the Neurokinin-1 Receptor Antagonist VPD-737 in Subjects with Prurigo Nodularis||2016-06-08||due-trials|
|Reported results||2017-003250-16||A Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Refractory Chronic Cough||2018-09-06||due-trials|
|Listed as ongoing, but also has a completion date||2017-004210-25||A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Prurigo Nodularis||2020-02-06||bad-data|
|Ongoing||2017-004211-40||An Open-Label Long-Term Safety Study of Serlopitant for the Treatment of Pruritus||not-yet-due|